Description
CINRYZE DELIVERY DIRECTLY TO THE PATIENT FOR 12 MONTHS
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-11-01+$143,878= $143,878
- Mod 12012-01-30+$76,905= $220,783
- Mod P000022012-10-12-$68,798= $151,986
- Mod P000032012-10-29+$12,471= $164,457
- Mod P000042012-11-21+$98= $164,555
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-11-01 | +$143,878 | $143,878 | CINRYZE DELIVERY DIRECTLY TO THE PATIENT FOR 12 MONTHS |
| Mod 1· FUNDING ONLY ACTION | 2012-01-30 | +$76,905 | $220,783 | CINRYZE DELIVERY DIRECTLY TO THE PATIENT FOR 12 MONTHS |
| Mod P00002· FUNDING ONLY ACTION | 2012-10-12 | −$68,798 | $151,986 | CINRYZE DELIVERY DIRECTLY TO THE PATIENT FOR 12 MONTHS |
| Mod P00003· FUNDING ONLY ACTION | 2012-10-29 | +$12,471 | $164,457 | CINRYZE DELIVERY DIRECTLY TO THE PATIENT FOR 12 MONTHS |
| Mod P00004· FUNDING ONLY ACTION | 2012-11-21 | +$98 | $164,555 | CINRYZE DELIVERY DIRECTLY TO THE PATIENT FOR 12 MONTHS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI MGHZQ16KEN33)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA26117F0002 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $588,793 | FY2017 |
| VA24216F1927 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $61,550 | FY2016 |
| VA25917E0759 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $34,194 | FY2016 |
| VA797P16A0020 | NAC PHARMACEUTICALS 36P797 · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2016 |
| VA24816F0837 | 248-NETWORK CONTRACT OFFICE 8 · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $68,497 | FY2016 |
| VA52816F0220 | 242-NETWORK CONTRACT OFFICE 02 · 6505 · DRUGS AND BIOLOGICALS | $184,649 | FY2016 |
Other recipients under Q517 from 437-FARGO VA MEDICAL CENTER (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26315J0526 | WONG PHARMACY SERVICES, INC. | 437-FARGO VA MEDICAL CENTER | $72,047 | FY2015 |
| VA26315J0471 | WONG PHARMACY SERVICES, INC. | 437-FARGO VA MEDICAL CENTER | $43,551 | FY2015 |
| VA26314J0843 | WONG PHARMACY SERVICES, INC. | 437-FARGO VA MEDICAL CENTER | $68,000 | FY2014 |
| VA26314J0844 | WONG PHARMACY SERVICES, INC. | 437-FARGO VA MEDICAL CENTER | $74,720 | FY2014 |
| VA26313J1716 | WONG PHARMACY SERVICES, INC. | 437-FARGO VA MEDICAL CENTER | $94,798 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26312F0144_3600_VA797BP0469_3600 · retrieved 2026-09-26.